SCHEMBL27249148

SCHEMBL27249148

O=c1c(Nc2ccccc2)c(Nc2ccc(Cl)cc2)c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 11/20 0.63
PLK1 P53350 1/20 0.50
GSK3B P49841 2/20 0.49
CHEK1 O14757 1/20 0.49
MAP4K4 O95819 1/20 0.49
CHEK2 O96017 1/20 0.49
PRKCG P05129 1/20 0.49
PRKACA P17612 1/20 0.49
RPS6KB1 P23443 1/20 0.49
AKT1 P31749 1/20 0.49
FLT4 P35916 1/20 0.49
GSK3A P49840 1/20 0.49
RPS6KA3 P51812 1/20 0.49
NEK4 P51957 1/20 0.49
CSNK1G2 P78368 1/20 0.49
PRKCD Q05655 1/20 0.49
PRKAA1 Q13131 1/20 0.49
PRKG2 Q13237 1/20 0.49
ROCK1 Q13464 1/20 0.49
PRKG1 Q13976 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30673026 0.90 CYP1A2 (0.56) CXCR2PLK1GSK3BCHEK1MAP4K4
SCHEMBL24137170 0.87 CXCR2 (0.66) CXCR2PLK1ALDH1A1ALOX15TSHR
SCHEMBL22198065 0.87 CXCR2 (0.67) CXCR2PLK1ALDH1A1ALOX15TSHR
SCHEMBL30673015 0.87 CNR1 (0.57) CXCR2GSK3B
SCHEMBL31318779 0.83 CHEK2 (0.69) CXCR2GSK3BCHEK1MAP4K4CHEK2
SCHEMBL10339857 0.83 CXCR2 (0.53) CXCR2PLK1GSK3BCHEK1ALDH1A1
SCHEMBL1118626 0.82 ALDH1A1 (0.72) GSK3BALDH1A1ALOX15TSHRALOX12
SCHEMBL9479942 0.82 ALDH1A1 (0.72) GSK3BALDH1A1ALOX15TSHRALOX12
SCHEMBL30673004 0.81 MEN1 (0.62) CXCR2GSK3BCHEK1MAP4K4CHEK2
SCHEMBL30673035 0.78 MEN1 (0.52) CXCR2GSK3BCHEK1MAP4K4CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235548-A1 SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS RESEARCH TRIANGLE INSTITUTE (US) 2023-12-07 WO disclosed